Aaron Paul Kithcart: When Clinical Research Comes Together at ISTH 2026
Aaron Paul Kithcart, Senior Medical Director in Translational and Clinical Sciences of Hematology at Regeneron, shared a post on LinkedIn:
“Just returned from Paris for ISTH, and the only thing hotter than the conference was the temperature. Seriously!
We shared new data from our FXI and FXII programs, which is always a great opportunity to learn from global leaders in thrombosis. The whole team learned a lot from our interactions, proving once again the value of in person meetings.
We also sat down with investigators for our ongoing and future studies. Nothing replaces a real conversation, clinical research really is a partnership, and I appreciate those who set aside time to talk to us.
And honestly, half the value of ISTH is catching up with colleagues I only see once a year. See you again in Vancouver in 2027!”
Stay updated with Hemostasis Today.
-
Sep 1, 2026, 06:14Paolo Albino Ferrari: AnemiaScore for Cancer-Related Anemia Management
-
Sep 1, 2026, 04:27Ruth Fein: The Patient Impact of Transfusion Dependence in Myelofibrosis
-
Sep 1, 2026, 02:41Richard Buka: Win a Trip to ASH or ISTH 2027
-
Sep 1, 2026, 02:38Christian’s Journey to Stability on Avatrombopag – ITP Support Association
-
Sep 1, 2026, 02:35Alexis Guédon: Is IL-6 Pathway Inhibition Reduce Cardiovascular Risk in Giant Cell Arteritis?
-
Aug 31, 2026, 17:11Chokri Ben Lamine: Early Recognition and Immediate Treatment of Catastrophic APS
-
Aug 31, 2026, 17:06Nikolaos Ktenopoulos: COMPASS-ARTeCAT Trial Highlights Arterial Thrombosis in Patients With Cancer
-
Aug 31, 2026, 17:01Mark Kaplan: Same LDL-C, Different Coagulation, Different Outcomes, in FH
-
Aug 31, 2026, 16:55Kemal Karaagac: Milvexian Did Not Reduce Ischemic Events but Did Not Increase Fatal Bleeding